pfizer glp-1 agonist While Lilly and Novo dominate today's $50B+ obesity market, is preparing a killer portfolio to steal the spotlight in 2030s The Emotional Arc — From

Unlike diabetic ketoacidosis, the diagnosis of euglycemic diabetic ketoacidosisis often overlooked because of the absence of hyperglycemia.

Some studies link GLP-1 drugs for diabetes with neuroprotective benefits but others say that some of these drugs may increase depression risk, a new review concludes.

GLP-1 gastroparesis can look like routine side effects

Treatment with GLP1RAs resulted in unaffected or reduced Cmax and delayed tmax of drugs with high solubility and permeability (warfarin, contraceptive pills, acetaminophen), drugs with high solubility and low permeability (angiotensin converting enzyme inhibitors), drugs with low solubility and high permeability (statins) and drugs with low solubility and permeability (digoxin)

Lindsay R

At the end of 2025 we saw Eli Lillys Phase 3 TRIUMPH-4 trial for retatrutide read out